Guest: Lawrence Cohen, PhD
Host: Bruce Japsen
Why aren't there medications to treat atherosclerosis or, more specifically, the underlying chronic inflammation of the blood vessel walls associated with this condition? Dr. Lawrence Cohen, president and CEO of VIA Pharmaceuticals, tells the Chicago Tribune's Bruce Japsen about the coming medications in U.S.-approved clinical trials to treat this inflammatory process.
